Navigation Links
Questcor Announces Quarterly Cash Dividend and Provides Update on Share Repurchase Program
Date:12/11/2013

ANAHEIM, Calif., Dec. 11, 2013 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced that its Board of Directors has declared a quarterly cash dividend of $0.30 per share ($1.20 per share on an annual basis). The dividend will be paid on or about January 24, 2014 to shareholders of record at the close of business on January 17, 2014.

The Company also announced today that it made open market purchases during the fourth quarter of 2013 of approximately 500,000 shares of Questcor common stock through December 10, 2013. The shares were purchased at an average price of $57.21 per share.

Through its repurchase program and its dividend, Questcor has returned approximately $440 million to shareholders since the beginning of 2008, representing approximately 60% of its operating cash flow over that same period.

About Questcor                                                                                     

Questcor Pharmaceuticals, Inc. is a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Questcor also provides specialty contract manufacturing services to the global pharmaceutical industry through its wholly-owned subsidiary BioVectra Inc. Questcor's primary product is H.P. Acthar® Gel (repository corticotropin injection), an injectable drug that is approved by the FDA for the treatment of 19 indic
'/>"/>

SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Questcor Pharmaceuticals to Present at the Oppenheimer Annual Healthcare Conference
2. Biologics License Applications, Event Participations, and Stock Movements - Research Report on Baxter, WellPoint, Questcor Pharmaceuticals, CareFusion, and Hologic
3. Product Reviews, Recognitions, FDA Responses, and New Leadership Appointments - Research Report on Gilead, WellPoint, Questcor, Forest Laboratories, and Envision Healthcare
4. Questcor Honored as an "Everyday Hero" by NephCure Foundation
5. Questcor Adds G. Kelly Martin to Board of Directors
6. Questcor Pharmaceuticals to Present at the 2013 Credit Suisse Annual Healthcare Conference
7. Questcor Reports Third Quarter Financial Results
8. Questcor To Commence Phase 2 Study of Acthar for Acute Respiratory Distress Syndrome
9. Questcor Pharmaceuticals to Participate in Morgan Stanley Global Healthcare Conference
10. Morning Research: BioCryst Pharma Inc., Questcor Pharma Inc., PDL BioPharma Inc., and Amgen Inc.
11. Questcor to Commence Phase 2 Study of Acthar for ALS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)...  Today, in final recognition of the Centers for ... 1-800 Contacts is sharing how to keep lens cases ... who do not properly care for their lens cases ... Most contact lens wearers understand the importance ... case is sometimes overlooked.  When proper steps to clean ...
(Date:8/28/2015)... DUBLIN , Aug. 28, 2015 ... ) has announced the addition of the ... report to their offering. Developed by ... selective prostaglandin receptor agonist which effectively reduces intraocular ... by FDA, latanoprost (under the trade name of ...
(Date:8/28/2015)... 28, 2015 Perrigo Company plc ("Perrigo") (NYSE: ... N.V. ("Mylan") (NASDAQ: MYL ) shareholder vote regarding ... "Our views of Mylan,s offer to Perrigo shareholders have ... our Board,s careful reflection of the value available to ... choices that Mylan has allowed its shareholders to consider," ...
Breaking Medicine Technology:1-800 Contacts Shares Tips on How to Clean Lens Cases 2China Latanoprost Market Investigation Report 2015-2019 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 4Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 5
... The Cleveland Clinic and Valence Health announced today that ... become a clinically integrated network.  This new network, the ... physicians, and more than 1,000 private practitioners in the ... Physician Partnership (CPP), recognized the need to pursue Clinical ...
... Biotechnology, Inc. (OTC Bulletin Board: CSBR ), ... accelerating the development and enhancing the value of oncology ... Chief Financial Officer. Mr. Schonau indicated that he has ... other opportunities. Champions is seeking chief financial officer candidates ...
Cached Medicine Technology:Valence Health Selected by Cleveland Clinic to Support Clinical Integration Program 2Champions' CFO Resigns 2
(Date:8/30/2015)... ... August 30, 2015 , ... Nutritional Products ... lead the expansion of global cosmeceutical and skin care brands. Mr. Fernandez ... the last 25 years working in operations, purchasing and management for some of ...
(Date:8/29/2015)... (PRWEB) , ... August 30, 2015 , ... ... Sept. 15, 2015 — 1:30 p.m. – 3:00 p.m. EDT, http://www.fdanews.com/electronicinformedconsent ... than a simple digital handwritten signature. , Clinical trial sites can ...
(Date:8/29/2015)... ... August 29, 2015 , ... Dr. Tim Novelli, DC., Founder ... mission is to increase acceptance of the chiropractic field in the military. All too ... them. Although Chiropractic was made available to the VA program over a decade ...
(Date:8/29/2015)... ... August 29, 2015 , ... ... the localized area with stretching, soft tissue manipulation. Platelet rich plasma injections also ... shown through research to improve treatment outcomes. This localized treatment seems to ...
(Date:8/28/2015)... Nevada (PRWEB) , ... August 28, 2015 , ... An ... its decision to make the purchase of CPAP equipment more affordable by offering shipping ... includes all types of CPAP products and orders of any size. My Cpap Store ...
Breaking Medicine News(10 mins):Health News:NPI Executive Vice President Leads Cosmeceutical Expansion 2Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 2Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 3Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 4Health News:The Patriot Project brings Chiropractic Care to the Armed Forces and their Families - Rapid Release Technology Joins the Effort to Recruit more Doctors to Pledge 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 3Health News:My Cpap Store Now Offering Delivery Special 0 Cost to You 2
... , WASHINGTON, Sept. 18 The ... every VA medical site with endoscopic equipment, independently verifying the ... and sterile procedures for reprocessing endoscopic equipment across the country. ... provide the highest quality care to the Veterans of this ...
... in hospital patients also leads to higher costs, study ... popular stomach acid reducer greatly increases the risk of ... study has found. , Researchers at Wake Forest University ... of 834 cardiothoracic surgery patients on breathing machines who ...
... , WASHINGTON, Sept. 18 In response to the ... Max Baucus, DMLR Chairman Stuart L. Weinstein, M.D. issued the following ... Baucus is inadequate in addressing the serious problems caused by medical ... health care policy experts, opinion leaders, and patients all across the ...
... , , , WEINER,S NEW YORK ... , WASHINGTON, Sept. 18 The Public Option is still ... ,fading, nor ,waning, (New York Times) nor on ,life support, (ABC News)," says ... Health subcommittee, and later spokesman for the White House National Drug Policy Office. ...
... , , IDAHO FALLS, Idaho, ... announces the successful conclusion of a private placement completed among ... International Isotopes Inc. successfully completed a private placement ... $1 million. In this private placement, the Company offered ...
... N.Y., Sept. 18 IPRO has won a new ... research findings aimed at improving the quality and safety ... Agency for Healthcare Research and Quality,s (AHRQ,s) Knowledge Transfer/Implementation ... accelerated dissemination of evidence-based products that improve the quality ...
Cached Medicine News:Health News:Inspector General Completes Study of VA Endoscopic Programs 2Health News:Ulcer Preventative May Raise Pneumonia Risks 2Health News:Statement From Stuart L. Weinstein, MD, Chairman, Doctors for Medical Liability Reform on Senator Baucus' Health Care Reform Proposal 2Health News:Public Option Still Viable As House Set to Pass It -- Not 'Fading,' Says Robert Weiner, Former House Aging Committee Director 2Health News:International Isotopes Inc. Announces Successful Completion of a Private Placement 2Health News:International Isotopes Inc. Announces Successful Completion of a Private Placement 3Health News:IPRO Wins Knowledge Transfer/Implementation Federal Contract From AHRQ 2
Large, bright images from a bronchoscope designed for routine examination and treatment....
... The BF-1T40 has been designed with ... versatility in therapeutic applications. This permits the ... including those for electrosurgical procedures. In addition, ... wide field of view and a bright, ...
... High performance fiberoptic imaging from ... ,Olympus has improved its fiberscope range, ... specifications and enhanced image performance. Olympus ... instruments for diagnosis and therapy in ...
... scope designed specifically to enable direct inspection ... suitable for pediatric applications as well. Its ... mere 2.8mm across. As a result, insertion ... with greater ease. And since this sophisticated ...
Medicine Products: